THRX

Theravance, Inc. News Headlines

$26.77
*  
0.36
 negative 
1.33%
Get THRX Alerts
*Delayed - data as of Apr. 17, 2014 13:34 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Glaxo/THRX' Drug Gets FDA Nod - Analyst Blog
12/19/2013 12:10:01 PM - Zacks.com

Healthcare Stocks Staying Near Session Lows; Theravance Gains on Testing for Respiratory Drug
12/17/2013 4:54:32 PM - MT Newswires

Sector Update: Healthcare
12/17/2013 4:51:07 PM - MT Newswires

Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash E
12/13/2013 8:00:00 AM - Market Realist

Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash D
12/12/2013 4:00:00 PM - Market Realist

Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash C
12/12/2013 12:00:00 PM - Market Realist

Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash B
12/12/2013 8:00:00 AM - Market Realist

Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash A
12/11/2013 3:04:00 PM - Market Realist

Positive Data on Glaxo/Theravance Drug - Analyst Blog
12/9/2013 6:06:30 PM - Zacks.com

Glaxo/THRX's Relvar Approved in EU - Analyst Blog
11/19/2013 7:06:01 PM - Zacks.com

Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold
11/13/2013 7:56:38 PM - GuruFocus

Are You Betting Too Much On Theravance?
11/1/2013 11:28:00 AM - Seeking Alpha

Loss at Theravance Narrower Than Expected - Analyst Blog
10/25/2013 2:06:58 PM - Zacks.com

Novartis - Make Money From COPD Opportunity
10/7/2013 1:59:00 PM - Seeking Alpha

Japanese Approval for Theravance/Glaxo Drug - Analyst Blog
9/23/2013 11:39:20 AM - Zacks.com

Novartis' Ultibro Breezhaler Approved in Europe - Analyst Blog
9/23/2013 11:39:13 AM - Zacks.com

CHMP Positive on GSK/THRX candidate - Analyst Blog
9/20/2013 11:30:01 AM - Zacks.com

Sector Update: Healthcare Shares Mixed Pre-Market; Sarepta Sinks 10% on GlaxoSmithKline, Prosensa Study
9/20/2013 8:22:09 AM - MT Newswires

Sector Update: Healthcare
9/20/2013 8:17:31 AM - MT Newswires

FDA Panel Backs THRX/GSK Candidate - Analyst Blog
9/11/2013 6:58:03 PM - Zacks.com

Sector Update: Healthcare
9/11/2013 3:48:23 PM - MT Newswires

Healthcare Stocks Still Higher Near Bell; Theravance Rallies After FDA Advisory Panel Recommends New COPD Drug
9/11/2013 3:46:34 PM - MT Newswires

Encouraging News from THRX's TD-4208 - Analyst Blog
9/5/2013 11:50:01 AM - Zacks.com

Theravance Is Splitting Into Two Very Appealing Companies With Medium-Term Upside Of At Least 50%
8/30/2013 9:58:00 AM - Seeking Alpha

Good News for Theravance - Analyst Blog
8/15/2013 5:15:01 PM - Zacks.com